HakopGevorkyanMD

Internal Medicine • Burbank, CA

Internal Medicine at Advance Health Medical Group

Join to view full profile

Dr. Gevorkyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gevorkyan's full profile

Already have an account?

Office
333 E Magnolia Blvd
Ste 103
Burbank, CA 91502
Phone+1 818-848-1555

Fax+1 818-842-9323

Education & Training

Adventist Health White MemorialResidency, Internal Medicine, 1996 - 1999
Keck School of Medicine of the University of Southern CaliforniaClass of 1996

Certifications & Licensure

CA State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Amazing Charts EHR, AmazingCharts, LLC, 2012-2013

Clinical Trials

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease Start of enrollment: 2013 Jan 01
Terminated
Phase 1
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease Start of enrollment: 2014 Jun 01
Terminated
Phase 1, Phase 2
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects Start of enrollment: 2016 Feb 18
Completed
Phase 1
A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) Start of enrollment: 2016 Apr 25
Completed
Phase 1
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis Start of enrollment: 2018 Nov 29
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

6 citations
Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the(lateral thigh) muscles of healthy adult participants.
Kelong Han, Hakop Gevorkyan, Jafar Sadik Shaik, Herta Crauwels, Claudia Leemereise
Antimicrobial Agents and Chemotherapy. 2024-01-10
5 citations
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll-like Receptors 7 and 8, in Healthy Volunte...
Naoto Yamakawa, Fumitoshi Tago, Kenya Nakai, Yasumi Kitahara, Shingo Ikari
Clinical Pharmacology in Drug Development. 2023-04-01
9 citations
Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.
Wei Yin, Fahimeh Mamashli, Derek L. Buhl, Polyna Khudyakov, Dmitri Volfson
British Journal of Clinical Pharmacology. 2021-07-31